Cancer-associated fibroblasts and its derived exosomes: a new perspective for reshaping the tumor microenvironment

Cancer-associated fibroblasts (CAFs) are the most abundant stromal cells within the tumor microenvironment (TME). They extensively communicate with the other cells. Exosome-packed bioactive molecules derived from CAFs can reshape the TME by interacting with other cells and the extracellular matrix,...

Full description

Saved in:
Bibliographic Details
Published in:Molecular medicine (Cambridge, Mass.) Mass.), 2023-05, Vol.29 (1), p.66-66, Article 66
Main Authors: Peng, Zhiwei, Tong, Zhiwei, Ren, Zihao, Ye, Manping, Hu, Kongwang
Format: Article
Language:English
Subjects:
Adipocytes
Cancer-Associated Fibroblasts
Cell Line, Tumor
Cytokines
Diagnosis
Exosomes
Exosomes - metabolism
Fibroblasts
Fibroblasts - metabolism
Growth factors
Humans
Medical prognosis
Metastasis
MicroRNAs - genetics
MicroRNAs - metabolism
Neoplasms - metabolism
Pancreatic cancer
Physiology
Review
Signal transduction
Smooth muscle
Stem cells
Therapy
Tumor Microenvironment
Tumorigenesis
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cancer-associated fibroblasts (CAFs) are the most abundant stromal cells within the tumor microenvironment (TME). They extensively communicate with the other cells. Exosome-packed bioactive molecules derived from CAFs can reshape the TME by interacting with other cells and the extracellular matrix, which adds a new perspective for their clinical application in tumor targeted therapy. An in-depth understanding of the biological characteristics of CAF-derived exosomes (CDEs) is critical for depicting the detailed landscape of the TME and developing tailored therapeutic strategies for cancer treatment. In this review, we have summarized the functional roles of CAFs in the TME, particularly focusing on the extensive communication mediated by CDEs that contain biological molecules such as miRNAs, proteins, metabolites, and other components. In addition, we have also highlighted the prospects for diagnostic and therapeutic applications based on CDEs, which could guide the future development of exosome-targeted anti-tumor drugs.
ISSN:1528-3658
1076-1551
1528-3658
DOI:10.1186/s10020-023-00665-y